MTEX vs LFVN vs NATR vs NHTC

For growth investors, LifeVantage Corporation (LFVN) is the stronger pick with 14.

2% revenue growth year-over-year, versus -10. 7% for Mannatech, Incorporated (MTEX). Mannatech, Incorporated (MTEX) offers the better valuation at 3. 5x trailing P/E, making it the more compelling value choice. Analysts rate Nature's Sunshine Products, Inc. (NATR) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Mannatech, Incorporated (MTEX) is the cheapest at 3.

5x versus Nature's Sunshine Products, Inc. at 23. 2x.

Over the past 5 years, Nature's Sunshine Products, Inc.

(NATR) delivered a total return of +18. 8%, compared to -61. 0% for Mannatech, Incorporated (MTEX). Over 10 years, the gap is even starker: NATR returned +180. 2% versus NHTC's -63. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Mannatech, Incorporated (MTEX) is the lower-risk stock at 0.

27β versus LifeVantage Corporation's 1. 12β — meaning LFVN is approximately 318% more volatile than MTEX relative to the S&P 500. On balance sheet safety, Nature's Sunshine Products, Inc. (NATR) carries a lower debt/equity ratio of 12% versus 78% for Mannatech, Incorporated — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), LifeVantage Corporation (LFVN) is pulling ahead at 14.

2% versus -10. 7% for Mannatech, Incorporated (MTEX). On earnings-per-share growth, the picture is similar: LifeVantage Corporation grew EPS 230. 4% year-over-year, compared to -254. 0% for Natural Health Trends Corp.. Over a 3-year CAGR, NATR leads at 4. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

LifeVantage Corporation (LFVN) is the more profitable company, earning 4.

3% net margin versus -2. 2% for Natural Health Trends Corp. — meaning it keeps 4. 3% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: LFVN leads at 5. 3% versus -4. 5% for NHTC. At the gross margin level — before operating expenses — LFVN leads at 80. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, NHTC (25.

0% yield), LFVN (3. 2% yield) pay a dividend. MTEX, NATR do not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, Natural Health Trends Corp.

(NHTC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 58), 25. 0% yield). Both have compounded well over 10 years (NHTC: -63. 6%, LFVN: -42. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (MTEX (Consumer Defensive) and LFVN (Consumer Defensive) and NATR (Consumer Defensive) and NHTC (Consumer Cyclical)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: MTEX is a small-cap deep-value stock; LFVN is a small-cap deep-value stock; NATR is a small-cap quality compounder stock; NHTC is a small-cap income-oriented stock. LFVN, NHTC pay a dividend while MTEX, NATR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.